Tagrisso 80 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26F00R4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,237
Award facts
- Contract value 100% obligated
- $11,236.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,236.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) under a firm fixed-price contract. The award was made on November 14, 2025, with an ultimate completion date of December 8, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued against the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026.
Tagrisso is a targeted cancer therapy used in the treatment of non-small cell lung cancer, and this procurement supports the Defense Health Agency's medical supply requirements for military and veteran healthcare systems. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, leveraging its extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The competitively awarded delivery order reflects the company's established capability to meet federal healthcare procurement standards and its role within DLA's pharmaceutical supply chain supporting military health programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F00R4?
SPE2DR26F00R4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26F00R4 worth?
The government has obligated $11,237 on SPE2DR26F00R4.
Is contract SPE2DR26F00R4 an order under another contract?
Yes. SPE2DR26F00R4 is a delivery order under SPE2DR25D2200, an indefinite delivery contract.
Was contract SPE2DR26F00R4 competed?
The extent of competition for SPE2DR26F00R4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award